Cosmos Health Eyes Doc Pharma in European GMP Deal
The letter of intent marks a potential transformative step for Cosmos Health's European manufacturing footprint and pro…
The letter of intent marks a potential transformative step for Cosmos Health's European manufacturing footprint and pro…
Combined entity targets Phase 1 trial initiation in mid-2027 for ulcerative colitis candidate, funded by concurrent pri…
The underlying filing describes a Canadian fighter-pilot training deal — outside F&B Industry News editorial scope.
The submitted press release describes a military pilot-training deal between Top Aces and Select Global International —…
The bare-bones GlobeNewswire filing offers no deal terms or acquirer identity — but the 8.3 form triggers when a party …
Deal expands AIT's aerospace and defense automation footprint; financial terms undisclosed.
The China-based fintech platform is targeting a move into AI-driven waste management as it seeks to diversify beyond fi…
The regulatory filing signals a reportable interest threshold has been crossed during an active offer or merger period.
Transaction closed in April 2026; new leadership targets expanded distribution and long-term profitability for the Danv…
The oilfield-technology merger marks another SPAC pairing seeking SEC clearance in mid-2026 as blank-check deal activit…
The deal would extend ZenaTech's Drone as a Service footprint into utilities, forestry and government alongside its agr…
Form 8.3 filings relate to UK takeover disclosure rules for equity positions — no F&B nexus identified.